newdrugapprovals.org
Kyowa Hakko Kirin Korea begins patient recruitment in phase I/II study of BIW-8962 in lung cancer
Kyowa Hakko Kirin Korea begins patient recruitment in phase I/II study of BIW-8962 in lung cancer Kyowa Hakko Kirin Korea Co., Ltd This Phase 1/2 study is designed to assess the following: safety a…